Tilray Brands (TSX:TLRY) EPS without NRI: C$-0.31 (TTM As of Feb. 2026)


TSX:TLRY Tilray Brands Inc TSX:TLRY
61 GF Score
Price C$6.52
GF Value C$17.43
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Tilray Brands EPS without NRI?

Tilray Brands TSX:TLRY -0.61% 61 EPS without NRI is C$-0.31 as of Feb. 2026. GuruFocus rates TSX:TLRY with a GF Score™ of 61/100 and a GF Value™ of C$17.43 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 785 Drug Manufacturers companies, Tilray Brands ranks worse than 127388.41% on this metric.

Tilray Brands's earnings per share without non-recurring items for the three months ended in Feb. 2026 was C$0.03. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Feb. 2026 was C$-0.31.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Tilray Brands's EPS without NRI or its related term are showing as below:

During the past 13 years, Tilray Brands's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 118.60% per year. The lowest was -117.40% per year. And the median was -26.80% per year.

TSX:TLRY's 3-Year EPS without NRI Growth Rate is not ranked *
in the Drug Manufacturers industry.
Industry Median: 9.7
* Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.

Tilray Brands's EPS (Diluted) for the three months ended in Feb. 2026 was C$-0.33. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Feb. 2026 was C$-18.93.

Tilray Brands's EPS (Basic) for the three months ended in Feb. 2026 was C$-0.33. Its EPS (Basic) for the trailing twelve months (TTM) ended in Feb. 2026 was C$-18.93.


Tilray Brands  (TSX:TLRY) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Tilray Brands EPS without NRI Related Terms


Tilray Brands EPS without NRI Historical Data

* Premium members only.

The historical data trend for Tilray Brands's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tilray Brands EPS without NRI Chart

Tilray Brands Annual Data
Trend May16 May17 May18 May19 May20 May21 May22 May23 May24 May25
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only -12.68 -3.56 -10.86 0.14 0.14

Tilray Brands Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.04 0.28 -0.17 -0.45 0.03

TSX:TLRY vs AQST, EOLS, NIKA: EPS without NRI Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Tilray Brands's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tilray Brands PE Ratio without NRI vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tilray Brands's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Tilray Brands's PE Ratio without NRI falls into.


TSX:TLRY
61GF Score
Tilray Brands Inc TSX:TLRY
EPS without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tilray Brands EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Feb. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.31

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of C$-0.31 mean?
Tilray Brands (TSX:TLRY) has a EPS without NRI of C$-0.31 as of Feb. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Tilray Brands and its competitors. According to the industry distribution chart, Tilray Brands ranks #999999 out of 785 companies in the Drug Manufacturers industry.
Is Tilray Brands' EPS without NRI too high?
Tilray Brands' current EPS without NRI is C$-0.31. Based on the distribution chart, Tilray Brands ranks #999999 out of 785 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Tilray Brands has a GF Score™ of 61/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Tilray Brands' EPS without NRI compare to AQST and EOLS?
According to the Drug Manufacturers industry distribution chart, Tilray Brands ranks #999999 out of 785 companies for EPS without NRI. This places Tilray Brands in the lower half of its industry. The industry median EPS without NRI is 9.70. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Drug Manufacturers company?
The median EPS without NRI among Drug Manufacturers companies is 9.70, based on 785 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Tilray Brands and its competitors. For the Drug Manufacturers industry, the median EPS without NRI is 9.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tilray Brands's current EPS without NRI is C$-0.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tilray Brands stock overvalued right now?
Based on GuruFocus' analysis, Tilray Brands (TSX:TLRY) is currently considered Possible Value Trap. The stock's GF Value™ is C$17.43, compared to a current price of C$6.52 — trading 62.6% below its estimated fair value. The current EPS without NRI is C$-0.31. Tilray Brands' overall GF Score™ is 61/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Tilray Brands (TSX:TLRY), the current EPS without NRI is C$-0.31 as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tilray Brands (TSX:TLRY) Overvalued in 2026?

Based on GuruFocus' analysis, Tilray Brands stock appears to be undervalued. The current stock price of C$6.52 is trading 62.6% below its estimated GF Value™ of C$17.43. GuruFocus considers Tilray Brands to be Possible Value Trap.

Key valuation signals for TSX:TLRY:

  • EPS without NRI: C$-0.31
  • GF Value™: C$17.43 vs. price of C$6.52 (62.6% below fair value)
  • GF Score™: 61/100 with 5 warning signs

No single metric tells the full story. See the TSX:TLRY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Tilray Brands Business Description

Address 265 Talbot Street West, Leamington, ON, CAN, N8H 5L4
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.
61GF Score

Get the complete analysis for TSX:TLRY

EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$6.52
Price
C$17.43
GF Value